Aug 18, 2025, 07:40

Colorectal Cancer Alliance — Project Cure CRC

High-risk/high-reward preclinical, translational, and clinical CRC research RFP to speed cures; collaborations and public–private partnerships strongly encouraged; rolling submissions with rapid decisions.

Eligibility Criteria:

Open to academic, non-profit, and industry investigators with MD/PhD (or equivalent).
Multiple mechanisms for early-career, senior, team science, pilot, and startup applicants.

Funding Details:

Young Investigator Accelerator: up to USD 100,000/year × 2 (max USD 200,000).
Senior Investigator Accelerator: up to USD 250,000/year × 2 (max USD 500,000).
Pilot Accelerator: up to USD 100,000/year × 2 (max USD 200,000).
Team Science Accelerator: up to USD 250,000/year × 2 (max USD 500,000).
Opportunistic (startups): up to USD 500,000 (1 year).
Indirect costs may be allowed up to 5% on a case-by-case basis.

Deadline:

Rolling call: applications accepted starting January 25; decisions typically within ~2 months of submission.

Where to Go for Further Information:

Apply via ProposalCentral (Project Cure CRC).
Program contacts: [email protected]; [email protected].

AI/ML Antibody drug conjugates cancer colorectal cancer Colorectal Cancer Alliance early detection immunotherapy liquid biopsy OncoDaily Oncology pilot-awards Project Cure CRC proposalCENTRAL startup funding Team Science

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

New FDA PreCheck Program to Boost U.S. Drug Manufacturing